Tag: Breast Cancer
-
Advancing Awareness and Innovation in Invasive Lobular Breast Cancer: Lessons from a Fred Hutch Event
Global Lobular Breast Cancer Day shines spotlight on ILC challenges and breakthroughs Last week, invasive lobular breast cancer (ILC) patients and their care teams gathered at Fred Hutch Cancer Center for a focused two-hour program. The event, held on October 15 to mark Global Lobular Breast Cancer Awareness Day, brought patient stories, epidemiological insights, and…
-
Mammography Study Shows Elevated Future Breast Cancer Risk with Initial Concordance of Radiologist and AI Interpretation
Overview A new retrospective study published in Radiology: Artificial Intelligence examines how agreement between radiologist interpretation and standalone AI assessment of screening mammography correlates with the risk of developing breast cancer within five years. The findings suggest that concordant positive results between radiologist and AI are associated with markedly higher future cancer risk than either…
-
Concordant AI–Radiologist Findings on Mammography Predict Higher Five-Year Breast Cancer Risk
How Concordant AI and Radiologist Readings Elevate Risk Signals A new retrospective study published in Radiology: Artificial Intelligence has found that when a screening mammogram yields concordant positive results from both the radiologist and an AI tool, the five-year risk of developing breast cancer is markedly higher than when both interpretations are negative. The study…
-
AI and Data Drive Alberta Cancer Care: Dr. Omar Khan’s Vision for a Healthier Future
Introduction: A physician who sees data as a patient ally In Calgary, Alberta, Dr. Omar Khan is turning data into a core component of cancer care. A medical oncologist who treats breast cancer and sarcoma at the Arthur J.E. Child Comprehensive Cancer Centre, Khan has long believed that artificial intelligence and advanced analytics will transform…
-
Data-Driven Cancer Care: How Dr. Omar Khan Is Rewriting Alberta’s Oncology Landscape
Turning Data Into Better Cancer Care In Calgary, Alberta, a physician-scientist is reshaping how cancer care is delivered by translating data into real-world improvements for patients. Dr. Omar Khan, a medical oncologist who treats breast cancer and sarcoma at the Arthur J.E. Child Comprehensive Cancer Centre (Arthur Child), has long believed that artificial intelligence and…
-
Helping Women Reclaim Their Bodies: The Nipple Sisters and Areola Restoration
Changing the Narrative of Recovery Breast cancer can alter more than the body’s silhouette; it can affect a woman’s sense of self. For many survivors, the final milestone in their healing journey is areola restoration—a precise, artful procedure that helps reclaim the body’s wholeness. Enter the Nipple Sisters, Carmelina Baccari and Kacie Rainey, internationally certified…
-
Data-Driven Cancer Care: Dr. Omar Khan’s AI Push in Alberta
Turning Data Into Better Cancer Care Dr. Omar Khan, a medical oncologist who treats breast cancer and sarcoma at the Arthur J.E. Child Comprehensive Cancer Centre in Calgary, has long believed that artificial intelligence will redefine health care. His early career insight—spotting the potential of data to guide clinical decisions—has evolved into a multi-faceted program…
-
Personalized TAMENDOX Therapy Boosts Tamoxifen Effectiveness in Early Breast Cancer
Introduction: A new twist in tamoxifen treatment Breast cancer remains the most commonly diagnosed cancer among women worldwide. In a decisive step toward more effective hormone therapy, the Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology (IKP) has unveiled TAMENDOX, a personalized treatment strategy designed to optimize tamoxifen’s impact for individual patients. This multicenter clinical study…
-
Personalized TAMENDOX Therapy Boosts Tamoxifen Effectiveness in Early-Stage Breast Cancer
New Personalized Therapy Aims to Improve Tamoxifen Effectiveness Breast cancer remains the most common cancer among women worldwide, and hormone receptor–positive cancers account for a significant portion of cases. In a notable advance, researchers at the Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology (IKP) have developed a personalized therapy designed to boost the effectiveness of…
-
New Personalized Therapy Boosts Tamoxifen Effectiveness in Breast Cancer Patients
Overview Breast cancer remains the most common cancer among women worldwide. Recent advances from the Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology (IKP) introduce a new personalized therapy, TAMENDOX, designed to tailor hormone treatment to individual patients. The goal is to improve the effectiveness of tamoxifen, a long-standing drug used to treat hormone-dependent breast cancer,…